First published 9/30/2026, 8:28:15 AM · Last updated 9/30/2026, 8:28:15 AM

Lösliche Immuncheckpoints als prädiktive Biomarker für das Ansprechen auf neoadjuvante FLOT-Therapie beim Magen- und GEJ-Karzinom

A journal article on soluble immune checkpoints as predictive biomarkers for response to neoadjuvant FLOT therapy in gastric and gastroesophageal junction cancer was published on 2026-08-01 by Georg Thieme Verlag KG. The supplied excerpt contains only publisher and content type and includes no methodological, location, or result details.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article addresses potential biomarkers for predicting response to a specific neoadjuvant therapy in gastric and GEJ cancer.

Sources

Lösliche Immuncheckpoints als prädiktive Biomarker für das Ansprechen auf neoadjuvante FLOT-Therapie beim Magen- und GEJ-Karzinom

Report an issue